GT Biopharma Ownership | Who Owns GT Biopharma?


OverviewForecastFinancialsChart

GT Biopharma Ownership Summary


GT Biopharma is owned by 4.25% institutional investors, 27.57% insiders, and 68.18% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 0.42% of GTBP shares. Fidelity Extended Market Index is the top mutual fund, with 0.39% of its assets in GT Biopharma shares.

GTBP Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockGT Biopharma4.25%27.57%68.18%
SectorHealthcare Stocks 218.58%11.00%-129.58%
IndustryBiotech Stocks 296.15%10.91%-207.06%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de9.74K0.42%$34.86K
Clearstead advisors865.000.04%$3.10K
Jones financial companies lllp300.000.01%$1.06K
Mount yale investment advisors46.000.00%$165.00
Blue bell private wealth management10.000.00%$36.00
Front row advisors1.00-$4.00
Ghp investment advisors---
Farther finance advisors---
Allworth financial lp1.00-$4.00

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ghp investment advisors---
Mount yale investment advisors46.00-$165.00
Blue bell private wealth management10.00-$36.00
Front row advisors1.00-$4.00
Jones financial companies lllp300.00-$1.06K
Farther finance advisors---
Allworth financial lp1.00-$4.00
Clearstead advisors865.00-$3.10K
Blackrock funding, inc. /de9.74K-$34.86K

Top Buyers

HolderShares% AssetsChange
Clearstead advisors865.00-865.00
Jones financial companies lllp300.00-300.00
Mount yale investment advisors46.00-46.00
Allworth financial lp1.00--
Blackrock funding, inc. /de9.74K--

Top Sellers

HolderShares% AssetsChange
Ghp investment advisors---33.00
Farther finance advisors---6.00
Front row advisors1.00--
Blackrock funding, inc. /de9.74K--
Blue bell private wealth management10.00--

New Positions

HolderShares% AssetsChangeValue
Clearstead advisors865.00-865.00$3.10K
Jones financial companies lllp300.00-300.00$1.06K
Mount yale investment advisors46.00-46.00$165.00

Sold Out

HolderChange
Farther finance advisors-6.00
Ghp investment advisors-33.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20252011.11%99,688-91.98%40.10%5-28.57%5150.00%
Dec 31, 20241820.00%1,242,247-0.30%652.11%7133.33%2-33.33%
Sep 30, 202415-6.25%1,246,00715.35%551.40%3-25.00%3-50.00%
Jun 30, 202416-5.88%1,080,160-7.61%630.88%4-6-53.85%
Mar 31, 20241-96.43%1-100.00%----100.00%1-75.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Extended Market Index12.81K0.39%-
Vanguard Institutional Extnd Mkt Idx Tr7.22K0.22%-3.29K
Spartan Extended Market Index Pool E4.50K0.20%4.26K
Spartan Extended Market Index Pool F4.62K0.14%-
Fidelity Series Total Market Index3.79K0.12%-470.00
Dimensional US Core Equity USD Acc2.20K0.10%-
Fidelity Total Market Index2.20K0.07%-
BlackRock Extended Equity Market K1.16K0.05%-
Dimensional US Sustainability Core 1 ETF1.64K0.05%-
DFA US Sustainability Core 1799.000.04%-

Recent Insider Transactions


DateNameRoleActivityValue
Apr 11, 2023Breen Michael Martin Executive Chairman/Interim CEOBuy$25.00K
Apr 06, 2023Ohri Manu CFO & SecretaryBuy$25.00K
Dec 22, 2020Wendel Bruce-Buy$12.19K
Nov 16, 2020Wendel Bruce-Buy$10.26K
Dec 22, 2020Wendel Bruce-Buy$3.85K

Insider Transactions Trends


DateBuySell
2023 Q22-
2023 Q1--
2022 Q3--
2022 Q2--
2022 Q1--

GTBP Ownership FAQ


Who Owns GT Biopharma?

GT Biopharma shareholders are primarily institutional investors at 4.25%, followed by 27.57% insiders and 68.18% retail investors. The average institutional ownership in GT Biopharma's industry, Biotech Stocks , is 296.15%, which GT Biopharma falls below.

Who owns the most shares of GT Biopharma?

GT Biopharma’s largest shareholders are Blackrock funding, inc. /de (9.74K shares, 0.42%), Clearstead advisors (865 shares, 0.04%), and Jones financial companies lllp (300 shares, 0.01%). Together, they hold 0.46% of GT Biopharma’s total shares outstanding.

Does Blackrock own GT Biopharma?

BlackRock is not among the top 10 institutional shareholders of GT Biopharma.

Who is GT Biopharma’s biggest shareholder by percentage of total assets invested?

Ghp investment advisors is GT Biopharma’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 GT Biopharma shares, valued at 0$.

Who is the top mutual fund holder of GT Biopharma shares?

Fidelity Extended Market Index is the top mutual fund holder of GT Biopharma shares, with 0.39% of its total shares outstanding invested in 12.81K GT Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools